Our results are in line with Karakasheva et al., which demonstrated that TCZ suppresses tumor growth in vivo in part via the inhibition of STAT3 and MEK/ERK signaling, and IL-6 mediates the crosstalk between tumor cells and activated fibroblasts in TME [58]. The gene discussed is MAP2K7; the disease is neoplasm.